MEI Pharma, Inc.
MEI Pharma, Inc. (MEIP) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
meip · pe ratio · data through Jun 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for MEI Pharma, Inc. (MEIP) measures how much investors pay for each dollar of the company's trailing earnings. MEIP's current PE ratio of N/A is calculated by dividing its stock price of $3.07 by its TTM earnings per share of -$9.13.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
MEI Pharma, Inc.You MEIP | $20M | N/A | — | -$9.13 |
 COSCIENS Biopharma Inc. CSCI | $9M | N/A | — | -$5.93 |
 Dominari Holdings Inc. DOMH | $51M | N/A | — | -$1.57 |
 Elevation Oncology, Inc. ELEV | $22M | N/A | — | -$0.78 |
 Kineta, Inc. KA | $7M | N/A | — | -$1.42 |
 LakeShore Biopharma Co., Ltd LSB | $26M | N/A | — | -$0.94 |
 MetaVia Inc. MTVA | $5M | N/A | — | -$7.35 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-06-30Latest FY2025 | — | $-2.39 | — | |
2024-06-30 FY2024 | 1.07x | $2.67 | — | |
2023-06-30 FY2023 | — | $-4.78 | — | |
2022-06-30 FY2022 | — | $-8.75 | — | |
2021-06-30 FY2021 | — | $-7.34 | — | |
2020-06-30 FY2020 | — | $-10.37 | — | |
2019-06-30 FY2019 | — | $-4.73 | — | |
2018-06-30 FY2018 | — | $-19.34 | — | |
2017-06-30 FY2017 | 33.06x | $1.45 | — | |
2016-06-30 FY2016 | — | $-12.20 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for MEI Pharma, Inc. (MEIP) measures how much investors pay for each dollar of the company's trailing earnings. MEIP's current PE ratio of N/A is calculated by dividing its stock price of $3.07 by its TTM earnings per share of -$9.13.
Frequently asked questions
MEIP pe ratio · 6 questionsMEIP's current PE ratio is N/A as of 2026-06-09, based on a stock price of $3.07 and TTM EPS of -$9.13. Data sourced from Financial Modeling Prep via MEIP's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · MEI Pharma, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09